These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 526000)

  • 1. Pharmacokinetics of cefotaxime.
    Fu KP; Aswapokee P; Ho I; Matthijssen C; Neu HC
    Antimicrob Agents Chemother; 1979 Nov; 16(5):592-7. PubMed ID: 526000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefotaxime kinetics after multiple-dose intramuscular study in healthy volunteers.
    Harvengt C; Wauters G; Meunier H
    Chemotherapy; 1981; 27(3):173-8. PubMed ID: 6262022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses.
    Neu HC; Aswapokee P; Fu KP; Ho I; Matthijssen C
    Clin Pharmacol Ther; 1980 May; 27(5):677-85. PubMed ID: 6245831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cephanone in healthy adult volunteers.
    Regamey C; Kirby WM
    Antimicrob Agents Chemother; 1973 Dec; 4(6):589-92. PubMed ID: 4793878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
    Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
    Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.
    Neu HC
    Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
    Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ceforanide.
    Ripa S; La Rosa F; Ghezzi A; Prenna M; Pfeffer M
    Antimicrob Agents Chemother; 1982 Feb; 21(2):323-6. PubMed ID: 7073268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pharmacology of cefotaxime (HR 756), a new cephalosporin.
    Lüthy R; Münch R; Blaser J; Bhend H; Siegenthaler W
    Antimicrob Agents Chemother; 1979 Aug; 16(2):127-33. PubMed ID: 485125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.
    Srinivasan S; Fu KP; Neu HC
    Antimicrob Agents Chemother; 1981 Feb; 19(2):302-5. PubMed ID: 6214989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.
    Lakings DB; Novak E; Friis JM; Lunan CM; Paxton LM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):271-7. PubMed ID: 3717932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of cefamandole as compared with cephalothin.
    Fong IW; Ralph ED; Engelking ER; Kirby WM
    Antimicrob Agents Chemother; 1976 Jan; 9(1):65-9. PubMed ID: 1259393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.
    Granneman GR; Sennello LT; Steinberg FJ; Sonders RC
    Antimicrob Agents Chemother; 1982 Jan; 21(1):141-5. PubMed ID: 6282203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of cefoperazone and cefamandole.
    Srinivasan S; Francke EL; Neu HC
    Antimicrob Agents Chemother; 1981 Feb; 19(2):298-301. PubMed ID: 6214988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.
    Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.
    Scully BE; Fu KP; Neu HC
    Am J Med; 1984 Oct; 77(4C):112-6. PubMed ID: 6093511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kinetics of cefotaxime in healthy subjects (author's transl)].
    Acar JF; Guibert J; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):559-63. PubMed ID: 6259593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers.
    Parsons JN; Romano JM; Levison ME
    Antimicrob Agents Chemother; 1980 Feb; 17(2):226-8. PubMed ID: 6446259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of ceftizoxime, a new cephalosporin. Single-dose study.
    Nakashima N; Suzuki K; Hashimoto H; Nishijima K
    J Clin Pharmacol; 1981 Oct; 21(10):388-95. PubMed ID: 6273456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.